Veracyte Inc at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 10:20PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Welcome, everybody. Good afternoon. My name is Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs. I've got the pleasure of hosting the Veracyte management team here with me today: CEO, Marc Stapley; and CFO, Rebecca Chambers. Marc, Rebecca, thank you very much for joining us.

Marc A. Stapley - Veracyte, Inc. - CEO & Director

Thank you for having us.

Rebecca Chambers - Veracyte, Inc. - Executive VP & CFO

Thank you for having us.

Questions and Answers:

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe if you could just kind of help us set the stage first, talk a little bit about sort of the most recent results, some of the trends you're seeing in your business and what you're kind of expecting for the second half of this year.

Marc A. Stapley - Veracyte, Inc. - CEO
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot